Saros Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Saros Therapeutics's estimated annual revenue is currently $2M per year.
- Saros Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Saros Therapeutics has 13 Employees.
- Saros Therapeutics grew their employee count by 8% last year.
Saros Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder, President | Reveal Email/Phone |
2 | Co-Founder, VP Development | Reveal Email/Phone |
3 | Co-Founder, SVP Regulatory Affairs | Reveal Email/Phone |
4 | VP Development | Reveal Email/Phone |
5 | Associate Research Scientist | Reveal Email/Phone |
6 | Principal Scientist | Reveal Email/Phone |
Saros Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.6M | 17 | -6% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $2.5M | 16 | 0% | N/A | N/A |
#4 | $803.3M | 3239 | 9% | $1.79M | N/A |
#5 | $2.8M | 18 | 64% | N/A | N/A |
#6 | $38.4M | 248 | 18% | N/A | N/A |
#7 | $2M | 13 | -24% | N/A | N/A |
#8 | $1.4M | 9 | -25% | N/A | N/A |
#9 | $1.4M | 9 | 0% | N/A | N/A |
#10 | $2.5M | 16 | 7% | N/A | N/A |
What Is Saros Therapeutics?
Saros Therapeutics is working to enhance patients' response to immunotherapy by harnessing the STING pathway with a strategy to overcome the limitations of prior STING agonists. In combination with existing immunotherapies, this approach has the potential to enable a safe and more effective immune response against the tumor than with immunotherapy alone.
keywords:N/AN/A
Total Funding
13
Number of Employees
$2M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.9M | 13 | 0% | $42.9M |
#2 | $1.7M | 13 | N/A | N/A |
#3 | $2.1M | 13 | N/A | N/A |
#4 | $1.4M | 13 | N/A | N/A |
#5 | $1.1M | 13 | N/A | N/A |